BioLineRx (BLRX) Research Hub

BioLineRx (BLRX) trades on NASDAQ, IL in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 2.01 USD (-1.47%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -1.36, market cap 0.01B. This hub links to the full technical, earnings and options research available for BLRX.

Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ

SectorHealthcare (Biotechnology)
ExchangeNASDAQ, IL
Last close2.01 USD (-1.47%)
52-week range1.945 USD – 3.49 USD
Trend regimeRange
14-day RSI31.8 (Bearish)
Trailing P/E-1.36
Market cap0.01B
Dividend yield0.00%
Next earnings2026-08-13

Available research for BLRX

Earnings

BLRX earnings date and last-quarter result: next report 2026-08-13, last quarter beat, P/E -1.36. Updated 2026-07-23.

Options: Covered Call

Covered Call on BLRX: how it works, illustrative setup around the real 2.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Iron Condor

Iron Condor on BLRX: how it works, illustrative setup around the real 2.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Options: Protective Put

Protective Put on BLRX: how it works, illustrative setup around the real 2.01 USD price, max profit/loss, breakeven and when to use it. Educational.

Technical

BLRX technical analysis: range, last 2.01 USD, RSI 31.8, 52w range 1.945 USD–3.49 USD, real support/resistance. Updated 2026-10-26.

More on SniperIQ

Frequently asked questions

What sector is BLRX in?

BioLineRx (BLRX) is classified under Healthcare (Biotechnology), listed on NASDAQ, IL.

Is BLRX in an uptrend or downtrend?

As of 2026-10-26, BLRX is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.

What is BLRX's trailing P/E ratio?

BLRX's trailing P/E is -1.36, with a market cap of 0.01B. See the earnings research page for full valuation detail.

When does BLRX next report earnings?

BLRX is next scheduled to report earnings on 2026-08-13.